Page last updated: 2024-08-20

pregnenolone and Adrenocortical Carcinoma

pregnenolone has been researched along with Adrenocortical Carcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BRYSON, MJ; SWEAT, ML1
Andreis, PG; Conconi, MT; Malendowicz, LK; Neri, G; Nussdorfer, GG; Parnigotto, PP; Petrelli, L; Rucinski, M1

Other Studies

2 other study(ies) available for pregnenolone and Adrenocortical Carcinoma

ArticleYear
LOSS OF TWO STEROID 11 BETA-HYDROXYLATING COMPONENTS IN A RAT ADRENOCORTICAL CARCINOMA.
    Journal of the National Cancer Institute, 1964, Volume: 33

    Topics: Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortical Carcinoma; Desoxycorticosterone; Metabolism; Neoplasms; Neoplasms, Experimental; Pregnenolone; Progesterone; Rats; Research

1964
Neuropeptides B and W enhance the growth of human adrenocortical carcinoma-derived NCI-H295 cells by exerting MAPK p42/p44-mediated proliferogenic and antiapoptotic effects.
    International journal of molecular medicine, 2005, Volume: 16, Issue:6

    Topics: Adrenocortical Carcinoma; Apoptosis; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Golgi Apparatus; Humans; Hydrocortisone; Imidazoles; Mitochondria; Mitogen-Activated Protein Kinase 3; Neuropeptides; Pregnenolone; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; RNA, Messenger

2005